393 related articles for article (PubMed ID: 17258719)
21. Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course.
Tacke F; Trautwein C; Yagmur E; Hellerbrand C; Wiest R; Brenner DA; Schnabl B
J Gastroenterol Hepatol; 2007 Aug; 22(8):1256-64. PubMed ID: 17688666
[TBL] [Abstract][Full Text] [Related]
22. Cytokine gene expression in cirrhotic and non-cirrhotic human liver.
Llorent L; Richaud-Patin Y; Alcocer-Castillejos N; Ruiz-Soto R; Mercado MA; Orozco H; Gamboa-Domínguez A; Alcocer-Varela J
J Hepatol; 1996 May; 24(5):555-63. PubMed ID: 8773910
[TBL] [Abstract][Full Text] [Related]
23. [The criteria of histological activity and the prognosis in precirrhotic alcoholic hepatopathies].
Oancea R; Serbănescu M; Lazăr V; Milcu V; Antonescu O
Med Interna; 1991; 43(1-2):103-11. PubMed ID: 1670114
[TBL] [Abstract][Full Text] [Related]
24. The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation.
Wells JT; Said A; Agni R; Tome S; Hughes S; Dureja P; Lucey MR
Liver Transpl; 2007 Dec; 13(12):1728-35. PubMed ID: 18044757
[TBL] [Abstract][Full Text] [Related]
25. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
[TBL] [Abstract][Full Text] [Related]
26. Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis.
Affò S; Dominguez M; Lozano JJ; Sancho-Bru P; Rodrigo-Torres D; Morales-Ibanez O; Moreno M; Millán C; Loaeza-del-Castillo A; Altamirano J; García-Pagán JC; Arroyo V; Ginès P; Caballería J; Schwabe RF; Bataller R
Gut; 2013 Mar; 62(3):452-60. PubMed ID: 22637703
[TBL] [Abstract][Full Text] [Related]
27. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.
Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M
Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352
[TBL] [Abstract][Full Text] [Related]
28. [Alcoholic hepatitis: epidemiologic nature and severity of the clinical course in Argentina].
Jmelnitzky A
Acta Gastroenterol Latinoam; 1987; 17(4):287-97. PubMed ID: 3505155
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
[TBL] [Abstract][Full Text] [Related]
30. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.
Sharma P; Kumar A; Sharma BC; Sarin SK
J Hepatol; 2009 Mar; 50(3):584-91. PubMed ID: 19155081
[TBL] [Abstract][Full Text] [Related]
31. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.
Louvet A; Wartel F; Castel H; Dharancy S; Hollebecque A; Canva-Delcambre V; Deltenre P; Mathurin P
Gastroenterology; 2009 Aug; 137(2):541-8. PubMed ID: 19445945
[TBL] [Abstract][Full Text] [Related]
32. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
33. Occlusive venous lesions in alcoholic liver disease. A study of 200 cases.
Goodman ZD; Ishak KG
Gastroenterology; 1982 Oct; 83(4):786-96. PubMed ID: 7106509
[TBL] [Abstract][Full Text] [Related]
34. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
35. Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis.
Nagula S; Jain D; Groszmann RJ; Garcia-Tsao G
J Hepatol; 2006 Jan; 44(1):111-7. PubMed ID: 16274836
[TBL] [Abstract][Full Text] [Related]
36. Morphological markers with predictive-evolutive value in liver diseases.
Banciu T; Tudose N
Med Interne; 1984; 22(4):297-301. PubMed ID: 6515294
[TBL] [Abstract][Full Text] [Related]
37. Distribution of hepatic nerve fibers in liver diseases.
Jaskiewicz K; Voigt MD; Robson SC
Digestion; 1994; 55(4):247-52. PubMed ID: 8063030
[TBL] [Abstract][Full Text] [Related]
38. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
39. Portal lymphocytic infiltrate in alcoholic liver disease.
Colombat M; Charlotte F; Ratziu V; Poynard T
Hum Pathol; 2002 Dec; 33(12):1170-4. PubMed ID: 12514784
[TBL] [Abstract][Full Text] [Related]
40. Morphology of alcoholic liver disease.
Lefkowitch JH
Clin Liver Dis; 2005 Feb; 9(1):37-53. PubMed ID: 15763228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
